Tonix Pharmaceuticals Holding Corp.
TNXP
$12.87
-$0.29-2.20%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 29.10M | 17.56M | 13.11M | 10.30M | 9.83M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 29.10M | 17.56M | 13.11M | 10.30M | 9.83M |
| Cost of Revenue | 4.71M | 7.28M | 6.64M | 6.77M | 6.95M |
| Gross Profit | 24.40M | 10.28M | 6.47M | 3.53M | 2.88M |
| SG&A Expenses | 125.96M | 106.20M | 87.68M | 67.59M | 49.60M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 194.53M | 168.74M | 138.81M | 110.20M | 92.22M |
| Operating Income | -165.43M | -151.19M | -125.70M | -99.90M | -82.38M |
| Income Before Tax | -159.67M | -147.39M | -124.02M | -99.22M | -81.42M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -159.67 | -147.39 | -124.02 | -99.22 | -81.42 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -159.67M | -147.39M | -124.02M | -99.22M | -81.42M |
| EBIT | -165.43M | -151.19M | -125.70M | -99.90M | -82.38M |
| EBITDA | -163.30M | -149.20M | -123.78M | -97.96M | -79.90M |
| EPS Basic | -12.93 | -14.35 | -14.26 | -20.05 | -39.15 |
| Normalized Basic EPS | -8.08 | -8.97 | -8.69 | -12.31 | -24.25 |
| EPS Diluted | -12.93 | -14.35 | -14.26 | -20.05 | -39.15 |
| Normalized Diluted EPS | -8.08 | -8.97 | -8.69 | -12.31 | -24.25 |
| Average Basic Shares Outstanding | 51.06M | 41.76M | 33.98M | 24.44M | 16.14M |
| Average Diluted Shares Outstanding | 51.06M | 41.76M | 33.98M | 24.44M | 16.14M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |